Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- 1 July 2010
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 53 (4), 702-712
- https://doi.org/10.1016/j.jhep.2010.04.025
Abstract
No abstract availableFunding Information
- Bonfor-Stiftung (O-107.0084, O-107.0103)
- Deutsche Forschungsgemeinschaft (SFB TRR57 P18)
- Swiss National Foundation for Scientific Research (320000-117725)
This publication has 29 references indexed in Scilit:
- Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosisLiver International, 2009
- Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potentialHepatology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cellsLiver International, 2008
- Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic ratsHepatology, 2007
- Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic ratsJournal of Hepatology, 2007
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology, 2007
- Rosuvastatin Treatment Prevents Progressive Kidney Inflammation and Fibrosis in Stroke-Prone RatsThe American Journal of Pathology, 2007
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- TGF-β1 Stimulation of Fibronectin Transcription in Cultured Human Lung Fibroblasts Requires Active Geranylgeranyl Transferase I, Phosphatidylcholine-Specific Phospholipase C, Protein Kinase C-δ, and p38, But Not erk1/erk2Archives of Biochemistry and Biophysics, 2000